Global In-Vitro Diagnostics Quality Control Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global In-Vitro Diagnostics Quality Control Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Products and Services (Quality Control Products, Data Management Solutions, and Quality Assurance Services), Application (Immunochemistry, Hematology, Molecular Diagnostics, Coagulation/Hemostasis, and Other Applications), End Users (Hospitals, Clinical Laboratories, IVD Manufacturers & CROs, and Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global In-Vitro Diagnostics Quality Control Market was valued at USD 1,598.1 million in 2023 and is expected to reach USD 2,490.0 million by 2031 while growing at a CAGR of 5.7% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global in-vitro diagnostics quality control market growth. Quality control in In-Vitro Diagnostics (IVD) encompasses a series of processes and procedures aimed at guaranteeing the precision, dependability, and uniformity of clinical tests conducted on specimens outside the body. These measures are indispensable for reducing errors, preserving the credibility of test outcomes, and safeguarding patient well-being.
The surge in IVD test adoption and advancements in quality control technology propel the in-vitro diagnostics (IVD) quality control market. Yet, cost constraints, budgetary pressures, and concerns regarding data security and privacy may impede market growth.
Furthermore, the global in-vitro diagnostics quality control industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Products and Services Analysis
The Global In-Vitro Diagnostics Quality Control Market is segmented among Quality Control Products, Data Management Solutions, and Quality Assurance Services, based on Products and Services. In 2023, Quality Control Products accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global In-Vitro Diagnostics Quality Control Market is segmented among Immunochemistry, Hematology, Molecular Diagnostics, Coagulation/Hemostasis, and Other Applications, based on Application. In 2023, Immunochemistry accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global In-Vitro Diagnostics Quality Control Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Abbott Laboratories, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Quidel Corporation, bioMerieux Inc., Qnostics Ltd, Microbiologics Inc., SeraCare Life Sciences Inc., Thermo Fisher Scientific, and ZeptoMetrix Corporation
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global In-Vitro Diagnostics Quality Control Market Dynamics
Drivers
Restraints
Opportunity
4. Global In-Vitro Diagnostics Quality Control Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global In-Vitro Diagnostics Quality Control Market Segmentation, By Products and Services
Global In-Vitro Diagnostics Quality Control Market Share Analysis, By Products and Services
Global In-Vitro Diagnostics Quality Control Market Growth Analysis, By Products and Services
Global In-Vitro Diagnostics Quality Control Market Trends, By Products and Services
o Quality Control Products
o Data Management Solutions
o Quality Assurance Services
6. Global In-Vitro Diagnostics Quality Control Market Segmentation, By Application
Global In-Vitro Diagnostics Quality Control Market Share Analysis, By Application
Global In-Vitro Diagnostics Quality Control Market Growth Analysis, By Application
Global In-Vitro Diagnostics Quality Control Market Trends, By Application
o Immunochemistry
o Hematology
o Molecular Diagnostics
o Coagulation/Hemostasis
o Other Applications
7. Global In-Vitro Diagnostics Quality Control Market Segmentation, By End Users
Global In-Vitro Diagnostics Quality Control Market Share Analysis, By End Users
Global In-Vitro Diagnostics Quality Control Market Growth Analysis, By End Users
Global In-Vitro Diagnostics Quality Control Market Trends, By End Users
o Hospitals
o Clinical Laboratories
o IVD Manufacturers & CROs
o Other End Users
8. Global In-Vitro Diagnostics Quality Control Market Segmentation, By Region
Global In-Vitro Diagnostics Quality Control Market Share Analysis, By Region
Global In-Vitro Diagnostics Quality Control Market Growth Analysis, By Region
Global In-Vitro Diagnostics Quality Control Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Abbott Laboratories*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche AG
Quidel Corporation
bioMerieux Inc.
Qnostics Ltd
Microbiologics Inc.
SeraCare Life Sciences Inc.
Thermo Fisher Scientific
ZeptoMetrix Corporation
*Similar analysis will be provided for each company listed above.
